ID: ALA4171295

Max Phase: Preclinical

Molecular Formula: C38H63ClN8O6

Molecular Weight: 763.42

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC[C@H](C)[C@@H]([C@@H](CC(=O)N1CCC[C@H]1[C@H](OC)[C@@H](C)C(=O)NCCc1ccc(Cl)cc1)OC)N(C)C(=O)[C@@H](NC(=O)[C@H](C(C)C)N(C)C)[C@H](C)N=[N+]=[N-]

Standard InChI:  InChI=1S/C38H63ClN8O6/c1-12-24(4)34(46(9)38(51)32(26(6)43-44-40)42-37(50)33(23(2)3)45(7)8)30(52-10)22-31(48)47-21-13-14-29(47)35(53-11)25(5)36(49)41-20-19-27-15-17-28(39)18-16-27/h15-18,23-26,29-30,32-35H,12-14,19-22H2,1-11H3,(H,41,49)(H,42,50)/t24-,25+,26-,29-,30+,32-,33-,34-,35+/m0/s1

Standard InChI Key:  KEUHRZOXSFUJDR-FBXGFABASA-N

Associated Targets(Human)

HCC1954 381 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

PC-3 62116 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 763.42Molecular Weight (Monoisotopic): 762.4559AlogP: 4.69#Rotatable Bonds: 21
Polar Surface Area: 169.28Molecular Species: ACIDHBA: 8HBD: 2
#RO5 Violations: 1HBA (Lipinski): 14HBD (Lipinski): 2#RO5 Violations (Lipinski): 2
CX Acidic pKa: -10.71CX Basic pKa: 8.03CX LogP: 4.31CX LogD: 3.47
Aromatic Rings: 1Heavy Atoms: 53QED Weighted: 0.10Np Likeness Score: 0.48

References

1. Dugal-Tessier J, Barnscher SD, Kanai A, Mendelsohn BA..  (2017)  Synthesis and Evaluation of Dolastatin 10 Analogues Containing Heteroatoms on the Amino Acid Side Chains.,  80  (9): [PMID:28885014] [10.1021/acs.jnatprod.7b00359]

Source